<< Nanobotmodels animates future DNA repairing process | U.S. bishops urge House members to fix flaws or oppose Senate health reform bill >>

Phase II Topical Interferon Alpha-2b trial for AGW: Helix BioPharma achieves last-patient-out

Published on March 22, 2010 at 3:52 AM · No Comments

Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today that it has achieved last-patient-out in its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW). Accordingly, all patients enrolled in the study have completed the prescribed study procedures, and Helix will now proceed to closing of the database and analysis of the results. Based on the trial design and schedule, final reporting is expected in mid to late calendar 2010, as previously announced.

SOURCE Helix BioPharma Corp.

28d90286-3047-48b4-8d52-678fe8bec727|0|.0

Posted in: Drug Trial News | Disease/Infection News

Tags: Cancer, Drug Delivery, Exercise, Genital Wart, RNA

CVS Caremark adds Access' MuGard to pharmacy benefit networkACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery p...
Progenics Pharmaceuticals reports net loss of $18.6M in first-quarter 2010Progenics Pharmaceuticals, Inc. today announced its results of operations for the quarter ended Marc...
GenMark Diagnostics files registration statement with Securities and Exchange CommissionGenMark Diagnostics, Inc. announced today that it has filed a registration statement with the Securi...
Experts say obese women should be refused fertility treatmentA fertility organisation in Britain is saying that severely obese women should be barred from having...
Aging population correlates with a switch from acute infectious diseases to chronic diseases as the major cause of morbidity and mortalitySome diseases like ulcers and certain types of cancer, once thought to be primarily related to lifes...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.